NEW YORK, Aug. 26 (GenomeWeb News) - Third Wave Technologies and 3M today announced a supply pact that will enable Third Wave's customers the option of coupling the firm's Invader DNA and RNA analytical chemistry technology with 3M's microfluidics technology.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.
Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.
The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.
Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.